NCT05483374 2026-04-03EURACANFondazione IRCCS Istituto Nazionale dei Tumori, MilanoRecruiting13,600 enrolled
NCT04985357 2024-11-25Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsTravera IncWithdrawn